Eloxx director granted 4,018 stock options at $11
Eloxx Pharmaceuticals director Steven D. Rubin received a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eloxx Pharmaceuticals director Steven D. Rubin received a new stock option grant. The award covers 4,018 options to buy Eloxx common stock at an exercise price of $11.00 per share and expires on June 8, 2036.
The option vests in 24 substantially equal monthly installments, becoming fully vested on the second anniversary of the June 8, 2026 grant date, as long as Rubin continues to provide service to the company. After this grant, he holds 4,018 stock options directly.
Insider Trade Summary
Grant/Award: 4,018 shares
Grant/Award
1 txn
Insider
Rubin Steven D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 4,018 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,018 contracts (Direct)
Footnotes (1)
- F1. The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
Key Figures
Option grant size: 4,018 options
Exercise price: $11.00 per share
Expiration date: June 8, 2036
+3 more
6 metrics
Option grant size
4,018 options
Stock Option (Right to Buy) granted June 8, 2026
Exercise price
$11.00 per share
Exercise price of granted stock options
Expiration date
June 8, 2036
Option term end date
Underlying shares
4,018 shares
Common stock underlying the options
Post-transaction options held
4,018 options
Total derivative holdings following grant
Vesting schedule
24 monthly installments
Fully vested on second anniversary of grant date
Key Terms
Stock Option (Right to Buy), exercise price, derivative, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "11.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
derivative financial
"transaction_type: "derivative""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
vesting financial
"The stock option will vest in 24 substantially equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Steven D. Rubin acquire in the latest ELOX Form 4 filing?
Steven D. Rubin received a grant of 4,018 stock options for Eloxx Pharmaceuticals common stock. These options give him the right to buy shares at a fixed $11.00 exercise price if the options vest and he chooses to exercise them before expiration.
What is the exercise price of Steven D. Rubin’s new Eloxx (ELOX) stock options?
The new stock options granted to Steven D. Rubin have an exercise price of $11.00 per share. This is the fixed price he would pay to acquire each share of Eloxx common stock if he exercises the options once they have vested.
How do Steven D. Rubin’s ELOX stock options vest according to the Form 4?
The stock options vest in 24 substantially equal monthly installments starting from the grant date. They become fully vested on the second anniversary of the grant date, provided Rubin maintains continuous service with Eloxx Pharmaceuticals through each applicable vesting date.
When do Steven D. Rubin’s Eloxx Pharmaceuticals stock options expire?
The granted stock options expire on June 8, 2036, if not exercised earlier. After that date, any unexercised options will lapse and no longer allow Rubin to purchase Eloxx common stock at the $11.00 exercise price.
How many Eloxx (ELOX) stock options does Steven D. Rubin hold after this transaction?
Following this grant, Steven D. Rubin holds a total of 4,018 stock options directly. This filing only shows this specific award and the resulting position; it does not provide information about any separate share holdings he may have.
What type of transaction is reported in Steven D. Rubin’s ELOX Form 4 filing?
The filing reports a stock option grant categorized as a derivative acquisition with code “A.” This indicates a grant, award, or other acquisition of derivative securities, rather than an open-market purchase or sale of Eloxx Pharmaceuticals common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates